Technologies
Turnstone Biologics Corp (NASDAQ:TSBX) Stock Has Fallen -87.89% YTD, What Do Analysts Anticipate Next?
In recent trading session, Turnstone Biologics Corp (NASDAQ:TSBX) saw 1.38 million shares changing hands at last check today with its beta currently measuring 1.26. Company’s